NCT03213509

Brief Summary

The purpose of this study is to conduct Verbal Autopsies of deaths ( stillbirths and neonatal deaths together) identified in the BetterBirth trial to identify their potential causes, timing, and social determinants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2017

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 11, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2017

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

June 5, 2019

Completed
Last Updated

October 17, 2019

Status Verified

October 1, 2019

Enrollment Period

2 months

First QC Date

July 7, 2017

Results QC Date

August 26, 2018

Last Update Submit

October 15, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Cause of Death

    Cause of perinatal mortality

    Early post-natal period (up to 7 days post-partum)

  • Cause of Stillbirth

    Cause of Stillbirth

    Early post-natal period (up to 7 days post-partum)

  • Cause of Early Neonatal Death

    Cause of Early Neonatal Death

    Early post-natal period (up to 7 days post-partum)

Other Outcomes (1)

  • Sex of Babies Who Suffered Perinatal Mortality

    Within 7 days postpartum

Study Arms (2)

Perinatal Death With Pause Point(s) Observed, Intervention Arm

Any perinatal death where one or more pause points was observed by BetterBirth staff (FADA) at 2 months or 6 months post-intervention launch, in the intervention arm of the BetterBirth Trial. The study involves administering verbal and social autopsies to the mother or family member of a baby who is in this cohort.

Other: Interview (Social and Verbal Autopsy)

Perinatal Death With Pause Point(s) Observed, Control Arm

Any perinatal death where one or more pause points was observed by BetterBirth staff (FADA) at 2 months or 6 months post-intervention launch, in the control arm of the BetterBirth Trial. The study involves administering verbal and social autopsies to the mother or family member of a baby who is in this cohort.

Other: Interview (Social and Verbal Autopsy)

Interventions

Verbal autopsy is a technique used to determine the cause of death by asking caregivers, friends or family members about signs and symptoms exhibited by the deceased in the period before death. This is usually done using a standardized questionnaire that collects details on signs, symptoms, complaints and any medical history or events. The cause of death, or the sequence of causes that led to death, are assigned based on the data collected by this questionnaire and on any other available information. The social autopsy tool is used in conjunction with the verbal autopsy tool to explore the non-biological factors contributing to a death, including the social, behavioural and health systems determinants of maternal and child deaths.

Perinatal Death With Pause Point(s) Observed, Control ArmPerinatal Death With Pause Point(s) Observed, Intervention Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Respondents for the neonatal deaths and stillbirths include mother, family members, or community members of the baby. Mothers had consented to follow-up as part of the BetterBirth Trial.

You may qualify if:

  • Mother, family members, and community members of deceased babies who enrolled in the BetterBirth Trial

You may not qualify if:

  • Mothers and family members members who did not consent to follow-up in the BetterBirth Trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Community Empowerment Labs

Shivgarh, Uttar Pradesh, 229308, India

Location

MeSH Terms

Conditions

Perinatal DeathStillbirth

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeathPathologic ProcessesPathological Conditions, Signs and SymptomsFetal Death

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Dr. Katherine Semrau
Organization
Ariadne Labs

Study Officials

  • Katherine Semrau, PhD

    Ariadne Labs

    PRINCIPAL INVESTIGATOR
  • Vishwajeet Kumar

    Community Empowerment Lab

    PRINCIPAL INVESTIGATOR
  • Arti Kumar

    Community Empowerment Lab

    PRINCIPAL INVESTIGATOR
  • Atul Gawande, MD, MPH

    Ariadne Labs

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 7, 2017

First Posted

July 11, 2017

Study Start

July 3, 2017

Primary Completion

August 27, 2017

Study Completion

August 27, 2017

Last Updated

October 17, 2019

Results First Posted

June 5, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will share

A de-identified data repository will hold the verbal autopsy data collected, including all data fields collected. At the end of the study, de-identified data will be shared in a public domain.

Locations